Literature DB >> 14985922

Apomorphine-induced disruption of prepulse inhibition that can be normalised by systemic haloperidol is insensitive to clozapine pretreatment.

H Russig1, W Spooren, S Durkin, J Feldon, B K Yee.   

Abstract

RATIONALE: Prepulse inhibition (PPI) of startle refers to the phenomenon in which a weak prepulse attenuates the startle response to a succeeding intense stimulus. PPI can be disrupted by systemic apomorphine in animals, and reduced PPI has been consistently reported in schizophrenia patients. The ability of the atypical antipsychotic clozapine to reverse apomorphine-induced PPI deficit has been demonstrated in the rat, but has not yet been tested in the mouse. The present study was designed to fill this gap. OBJECTIVE AND
RESULTS: We investigated the efficacy of clozapine in reversing apomorphine-induced (2.0 or 2.5 mg/kg, s.c.) PPI deficit in C57BL6 mice. Clozapine failed to restore PPI disruption in apomorphine-treated mice in two independent laboratories across two dose ranges (1-3 mg/kg, i.p., or 3-30 mg/kg, p.o.), whereas the typical antipsychotic haloperidol (1 mg/kg, i.p.) completely normalised PPI performance.
CONCLUSIONS: Unlike the rat, apomorphine-induced PPI disruption in mice might be instrumental in distinguishing between typical and atypical antipsychotic drugs. This also lends further support to the suggestion that the neuropharmacology of PPI is not identical in the two rodent species.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14985922     DOI: 10.1007/s00213-004-1810-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  13 in total

Review 1.  Multiparous species present problems (and possibilities) to developmentalists.

Authors:  E P Zorrilla
Journal:  Dev Psychobiol       Date:  1997-03       Impact factor: 3.038

2.  Differential effects of direct and indirect dopamine agonists on prepulse inhibition: a study in D1 and D2 receptor knock-out mice.

Authors:  Rebecca J Ralph-Williams; Virginia Lehmann-Masten; Veronica Otero-Corchon; Malcolm J Low; Mark A Geyer
Journal:  J Neurosci       Date:  2002-11-01       Impact factor: 6.167

3.  Comparison of apomorphine, amphetamine and dizocilpine disruptions of prepulse inhibition in inbred and outbred mice strains.

Authors:  G B Varty; N Walters; M Cohen-Williams; G J Carey
Journal:  Eur J Pharmacol       Date:  2001-07-13       Impact factor: 4.432

4.  Potentiation of prepulse inhibition of the startle reflex in rats: pharmacological evaluation of the procedure as a model for detecting antipsychotic activity.

Authors:  R Depoortere; G Perrault; D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1997-08       Impact factor: 4.530

Review 5.  Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review.

Authors:  M A Geyer; K Krebs-Thomson; D L Braff; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

Review 6.  Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.

Authors:  D L Braff; M A Geyer; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

7.  The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics?

Authors:  B Olivier; C Leahy; T Mullen; R Paylor; V E Groppi; Z Sarnyai; D Brunner
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

8.  Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity?

Authors:  A M Ouagazzal; F Jenck; J L Moreau
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

9.  Effects of phencyclidine (PCP) and (+)MK-801 on sensorimotor gating in CD-1 mice.

Authors:  P Curzon; M W Decker
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1998-01       Impact factor: 5.067

10.  Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.

Authors:  Rebecca J Ralph-Williams; Virginia Lehmann-Masten; Mark A Geyer
Journal:  Neuropsychopharmacology       Date:  2003-01       Impact factor: 7.853

View more
  13 in total

1.  A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction.

Authors:  B K Yee; R Keist; L von Boehmer; R Studer; D Benke; N Hagenbuch; Y Dong; R C Malenka; J-M Fritschy; H Bluethmann; J Feldon; H Möhler; U Rudolph
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-11       Impact factor: 11.205

2.  The effects of clozapine on quinpirole-induced non-regulatory drinking and prepulse inhibition disruption in rats.

Authors:  Lorenza De Carolis; Maria Antonietta Stasi; Ottaviano Serlupi-Crescenzi; Franco Borsini; Paolo Nencini
Journal:  Psychopharmacology (Berl)       Date:  2010-07-10       Impact factor: 4.530

3.  Antidepressant-like effects of Trichilia catigua (Catuaba) extract: evidence for dopaminergic-mediated mechanisms.

Authors:  Maria M Campos; Elizabeth S Fernandes; Juliano Ferreira; Adair R S Santos; João B Calixto
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

4.  Reversal of scopolamine-induced disruption of prepulse inhibition by clozapine in mice.

Authors:  Philipp Singer; Benjamin K Yee
Journal:  Pharmacol Biochem Behav       Date:  2011-12-21       Impact factor: 3.533

5.  The effects of pramipexole on prepulse inhibition and locomotor activity in C57BL/6J mice.

Authors:  Wei-Li Chang; Mark A Geyer; Mahalah R Buell; Martin Weber; Neal R Swerdlow
Journal:  Behav Pharmacol       Date:  2010-03       Impact factor: 2.293

6.  Disparate effects of pramipexole on locomotor activity and sensorimotor gating in Sprague-Dawley rats.

Authors:  Wei-li Chang; Michelle R Breier; Alex Yang; Neal R Swerdlow
Journal:  Pharmacol Biochem Behav       Date:  2011-06-12       Impact factor: 3.533

7.  Sensorimotor gating in NTS1 and NTS2 null mice: effects of d-amphetamine, dizocilpine, clozapine and NT69L.

Authors:  Alfredo Oliveros; Michael G Heckman; Maria Del Pilar Corena-McLeod; Katrina Williams; Mona Boules; Elliott Richelson
Journal:  J Exp Biol       Date:  2010-12-15       Impact factor: 3.312

8.  Administration of the Y2 receptor agonist PYY3-36 in mice induces multiple behavioral changes relevant to schizophrenia.

Authors:  Ulrike Stadlbauer; Wolfgang Langhans; Urs Meyer
Journal:  Neuropsychopharmacology       Date:  2013-06-10       Impact factor: 7.853

Review 9.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

10.  SSR504734 enhances basal expression of prepulse inhibition but exacerbates the disruption of prepulse inhibition by apomorphine.

Authors:  Philipp Singer; Weining Zhang; Benjamin K Yee
Journal:  Psychopharmacology (Berl)       Date:  2013-06-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.